Page last updated: 2024-08-23

colforsin and Neointima

colforsin has been researched along with Neointima in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, H; Hao, H; Li, Q; Ma, X; Peng, Z; Wang, M; Xu, C; Xu, Z; Zhang, Y; Zhu, L	1

Other Studies

1 other study(ies) available for colforsin and Neointima

Article	Year
The cyclic adenosine monophosphate elevating medicine, forskolin, reduces neointimal formation and atherogenesis in mice. Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:17 Topics: Animals; Aorta; Atherosclerosis; Blood Pressure; Cell Proliferation; Colforsin; Cyclic AMP; Disease Models, Animal; Endothelial Cells; Endothelium; Hyperplasia; Inflammation; Leukocytes; Medicine; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Signal Transduction	2020

Article

Year

The cyclic adenosine monophosphate elevating medicine, forskolin, reduces neointimal formation and atherogenesis in mice.

Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:17

Topics: Animals; Aorta; Atherosclerosis; Blood Pressure; Cell Proliferation; Colforsin; Cyclic AMP; Disease Models, Animal; Endothelial Cells; Endothelium; Hyperplasia; Inflammation; Leukocytes; Medicine; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Signal Transduction

2020